Blood pressure drug recalled over potentially life-threatening label mix-up


Blood pressure drug recalled over potentially life-threatening label mix-up

A drug maker is recalling one of its blood pressure medications over a labeling mix-up that it says could have potentially life-threatening consequences.

Accord Healthcare has recalled one lot of 12.5-milligram hydrochlorothiazide pills for the reason that one hundred-depend bottle became came upon to accept as true with one hundred spironolactone pills.

A pharmaceutical company has issued a voluntary nationwide recall of a popular blood pressure medication, hydrochlorothiazide, after a lot of the company's product was found to be mislabeled, the Food and Drug Administration said this week.

According to CBS News, the medicine that was filled inside of the bottles for blood pressure were actually medications to treat illnesses like congestive heart failure and cirrhosis of the liver.

For some, the medication mixup could be "life-threatening", according to the FDA's recall notice.

Hydrochlorothiazide tablets are used to manage hypertension either alone or with other antihypertensive drugs.

The hydrochlorothiazide tablets are light orange or peach in color, are round, and have an "H" on one side and a "1" on the other.

Use of spironolactone tablets instead of hydrochlorothiazide tablets poses the risk of contracting hyperkalemia (increase potassium levels) in certain people.

No patients have reported adverse effects in connection with the recall, the FDA says. Patients who have tablets that don't match the description should call their doctor or pharmacy for further instructions. The recall does not affect hydrochlorothiazide sold by other drug companies.

All the drugs in the valsartan recall were linked to Zhejiang Huahai Pharmaceuticals, in Linhai, China, which is where authorities believe the possible contamination may have taken place.